Specific Control of Pancreatic Endocrine β- and δ-Cell Mass by Class IIa Histone Deacetylases HDAC4, HDAC5, and HDAC9 - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Diabetes Année : 2011

Specific Control of Pancreatic Endocrine β- and δ-Cell Mass by Class IIa Histone Deacetylases HDAC4, HDAC5, and HDAC9

Olivia Lenoir
Kathleen Flosseau
  • Fonction : Auteur
Feng Xia Ma
  • Fonction : Auteur
Bertrand Blondeau
Antonello Mai
  • Fonction : Auteur
Rhonda Bassel-Duby
  • Fonction : Auteur
Philippe Ravassard
Eric Olson
  • Fonction : Auteur
Cécile Haumaitre
  • Fonction : Auteur
Raphaël Scharfmann
  • Fonction : Auteur

Résumé

OBJECTIVE Class IIa histone deacetylases (HDACs) belong to a large family of enzymes involved in protein deacetylation and play a role in regulating gene expression and cell differentiation. Previously, we showed that HDAC inhibitors modify the timing and determination of pancreatic cell fate. The aim of this study was to determine the role of class IIa HDACs in pancreas development. RESEARCH DESIGN AND METHODS We took a genetic approach and analyzed the pancreatic phenotype of mice lacking HDAC4, -5, and -9. We also developed a novel method of lentiviral infection of pancreatic explants and performed gain-of-function experiments. RESULTS We show that class IIa HDAC4, -5, and -9 have an unexpected restricted expression in the endocrine β- and δ-cells of the pancreas. Analyses of the pancreas of class IIa HDAC mutant mice revealed an increased pool of insulin-producing β-cells in Hdac5−/− and Hdac9−/− mice and an increased pool of somatostatin-producing δ-cells in Hdac4−/− and Hdac5−/− mice. Conversely, HDAC4 and HDAC5 overexpression showed a decreased pool of insulin-producing β-cells and somatostatin-producing δ-cells. Finally, treatment of pancreatic explants with the selective class IIa HDAC inhibitor MC1568 enhances expression of Pax4, a key factor required for proper β-and δ-cell differentiation and amplifies endocrine β- and δ-cells. CONCLUSIONS We conclude that HDAC4, -5, and -9 are key regulators to control the pancreatic β/δ-cell lineage. These results highlight the epigenetic mechanisms underlying the regulation of endocrine cell development and suggest new strategies for β-cell differentiation-based therapies.

Dates et versions

hal-03832421 , version 1 (27-10-2022)

Identifiants

Citer

Olivia Lenoir, Kathleen Flosseau, Feng Xia Ma, Bertrand Blondeau, Antonello Mai, et al.. Specific Control of Pancreatic Endocrine β- and δ-Cell Mass by Class IIa Histone Deacetylases HDAC4, HDAC5, and HDAC9. Diabetes, 2011, 60 (11), pp.2861-2871. ⟨10.2337/db11-0440⟩. ⟨hal-03832421⟩

Collections

UP-SANTE FRM
3 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More